In conclusion, our study demonstrates that as the matrix-laden and most abundant cells in bone, osteocytes—and their CM—can inhibit tumor progression and bone loss and that this capability is enhanced by activating Wnt signaling via Lrp5 and β-catenin overexpression. The gene discussed is LRP5; the disease is neoplasm.